Espicom Business Intelligence Ltd, Feb 2011, Pages: 648
- The manufacturing sector
Markets covered:
- Australia
- Brazil
- Canada
- France
- Germany
- Italy
- Japan
- Netherlands
- Russia
- Spain
- Switzerland
- UK
- USA The WorldGeneric Market Report
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for generic drugs across more than 2000 cities. For the year reported, estimates are given for the latent demand
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for generic prescription drugs across more than 2000 cities. For the year reported, estimates are given
ICON Group International, Jan 2011, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for over-the-counter generic drugs across more than 2000 cities. For the year reported, estimates are given
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for generic drugs across more than 2000 cities. For the year reported, estimates are given for the latent demand
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for generic prescription drugs across more than 2000 cities. For the year reported, estimates are given
ICON Group International, May 2009, Pages: 329
Market Potential Estimation Methodology Overview This study covers the world outlook for over-the-counter generic drugs across more than 2000 cities. For the year reported, estimates are given
Frost & Sullivan, March 2011, Pages: 48
and generics markets in Australia. The report ends with a competitive market analysis, which includes the top domestic companies in the Australia generics market.
Research Overview
This Frost & Sullivan
Business Insights, Aug 2010, Pages: 160
follow-on products will be prescribed, dispensed and consumed more widely in some of the world’s biggest markets. Governments and third-party payers will adopt more robust pro-generic policies in a bid
Cutting Edge Information, June 2010, Pages: 246
leaders.
40+ Pharmaceutical and Biotech Companies Profiled in this report
Countering Generic and Biosimilar Threats’ six chapters contain benchmarks detailing task force structure and staffing, as well
Decision Resources, Inc., Nov 2011
challenges and market uncertainties and may well offer only a short-term gain in global revenues at the expense of more lucrative, longer-term gain from R&D innovation.
This report discusses generics
RNCOS E-Services Private Limited, March 2011, Pages: 45
and become available to patients at a very low cost. Due to their low price nature, generic drugs are being used across the world and the governments are devising strategies to make them more accessible
Frost & Sullivan, March 2011, Pages: 49
and generics markets in South Korea. The report ends with a competitive market analysis, which includes the top domestic companies in the South Korea generics market
Research Overview
This Frost & Sullivan
RNCOS E-Services Private Limited, Feb 2012, Pages: 55
Japan is the world’s second largest pharmaceutical markets in the world, but due to public perception, the share of generic drugs has remained low in it. However, worried over rising healthcare
FirstWord Publishing, Oct 2010, Pages: 52
in limited income countries has also drawn international attention and won backing from the World Health Organization, the World Bank and Médecins Sans Frontières.
Generics have established their support
Dion Global Solutions Ltd., Sep 2010, Pages: 20
. The report “UK Generics Drugs Market Analysis” gives complete information on the impact of implementation of generic substitution law on the generic industry.
The consumer behavior and acceptance of generics
Euromonitor International, July 2011, Pages: 50
Generic drugs are usually associated with prescription (Rx) drugs; however, they are infiltrating the consumer health landscape via “branded generics” and private label across the world. Significant
RNCOS E-Services Private Limited, Sep 2011, Pages: 80
treatment. With increasing cancer incidences and competition in the healthcare industry around the world, the cancer market represents a lucrative sector for the generic players around the world due
Pharma-Reports, Jan 2012, Pages: 80
. This report offers an analysis of the impact of those trends, and reforms and regulations, particularly in the U.S. and the EU.
Key Trends Explored:
- Generic drug manufacturers are gearing up to take
Decision Resources, Inc., July 2010, Pages: 40
of off-label use; industry hopes and concerns for the future direction of government policy.
Key Terms for This Report:
Biosimilars, Cost-calculation method, Cost containment, Generics, Health technology
